Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
James Kinley Insider Profile
4 Followers
James Kinley, Chief Financial Officer at Medicure, holds 810.99K shares in Algernon Pharmaceuticals (Ticker: AGNPF), holds 47.10K shares in Medicure (Ticker: TSE:MPH).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+17.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that James Kinley holds in companies
Most Profitable Insider Trade
The most profitable trade made by James Kinley
James Kinley's Trading History
Medicure
Jun 11, 2018
Chief Financial Officer
Uninformative Sell
13.50K
C$55.11K
Algernon Pharmaceuticals
Feb 08, 2024
Chief Financial Officer
Uninformative Sell
―
$64.07K
List of latest transactions for each holding click on a transaction to see James Kinley's performance on stock
You May Also Like
James Kinley insider profile FAQ
What is the percentage of profitable transactions made by James Kinley?
The percentage of profitable transactions made by James Kinley is 67%.
What is the average return per transaction made by James Kinley?
The average return per transaction made by James Kinley is 17.10%.
What stocks does James Kinley hold?
James Kinley holds: TSE:MPH, AGNPF stocks.
What was James Kinley’s latest transaction?
James Kinley latest transaction was an Uninformative Sell of ―.
What was James Kinley's most profitable transaction?
James Kinley’s most profitable transaction was an Informative Buy of TSE:MPH stock on September 29, 2014. The return on the trade was 73.60%.
What is James Kinley's role in Medicure?
James Kinley's role in Medicure is Chief Financial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.